---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-004989"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2022-07-26T23:59:59+00:00"
generated_at: "2026-06-24T08:41:28.522555+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology appoints Julia Kirshner CSO, consolidates R&D to Pittsburgh

## Summary
- Julia Kirshner, Ph.D., appointed Chief Scientific Officer effective Aug 1, 2022; previously SVP and President of zPREDICTA.
- Employment agreement includes $380k base salary, bonus eligibility, 150,000 RSU LTIP, and $380k cash bonus if employed through July 2025.
- TumorGenesis division relocating from Salem, MA to Pittsburgh, PA; consolidation expected by Sept 30, 2022.
- Estimated restructuring costs of $250k for lease buyout and employee termination; two positions eliminated.
- Pittsburgh lab space expanding to accommodate growth and R&D activities.

## SEC filing metadata
- accession: 0001171843-22-004989
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2022-07-26T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.05, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184322004989/0001171843-22-004989-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184322004989/f8k_072622.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-004989
- JSON: https://secwatch.observer/filing/0001171843-22-004989.json
- Plain text: https://secwatch.observer/filing/0001171843-22-004989.txt

## Key facts
- Executive change
  Julia Kirshner was appointed as Chief Scientific Officer at Axe Compute Inc..
  - Action: appointed
  - Role: Chief Scientific Officer
  source text: On July 26, 2022 the Company announced that Julia Kirshner, Ph.D., has been appointed Chief Scientific Officer of the Company, effective August 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184322004989/0001171843-22-004989-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.